Literature DB >> 2950175

Determination of co-expression of activation antigens on proliferating CD4+, CD4+ CD8+ and CD8+ lymphocyte subsets by dual parameter flow cytometry.

P C Creemers.   

Abstract

The incidence of activation markers on proliferating CD4+, CD4+ CD8+ and CD8+ lymphocyte subsets was determined in a single laser Epics-C fluorescence-activated cell sorter system, using a series of double staining combinations. Experiments were performed after 3 days of culture with PHA on cell fractions enriched for CD4+ or CD8+ lymphocytes before initiation of culture. The percentage of CD4+, CD4+ CD8+ and CD8+ lymphocytes in the total population was determined using double staining with Leu3 PE for the detection of CD4+ cells, and Leu2 FITC for the detection of CD8+ cells. Next, double stainings with Leu3 and Leu2 antibodies conjugated with PE and antibodies directed against activation markers (M) IL-2 receptor, transferrin receptor, HLA-DR antigen and CALLA conjugated with FITC were performed, using the following combinations: Leu3 and Leu2/M, Leu3/M and Leu2/M. The expression of activation markers on CD4+ CD8+ lymphocytes was calculated from the results. Our findings indicate that CALLA is expressed on most CD4+ and all CD4+ CD8+ cells, and on a small percentage of CD8+ lymphocytes; the IL-2 receptor was expressed on most CD4+ cells, on approximately three-quarters of CD4+ CD8+ cells and half the CD8+ cells; HLA-DR was expressed on a small percentage of CD4+ cells, all CD4+ CD8+ cells and half of CD8+ cells. The transferrin receptor was almost exclusively expressed on CD4+ CD8+ cells. The standard deviation of the calculated values did not exceed 13% and this analysis can generally be applied to determine the co-expression of a third marker in a mixture of single and double stained cells using conventional methods.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2950175     DOI: 10.1016/0022-1759(87)90456-x

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  5 in total

1.  Immunostimulatory effects of the anionic alkali mineral complex Barodon on equine lymphocytes.

Authors:  Hyecheong Koo; Seung-Ho Ryu; Hyung Jin Ahn; Woo Kyung Jung; Young Kyung Park; Nam Hoon Kwon; So Hyun Kim; Jun Man Kim; Byung Woo Yoo; Soo Il Choi; William C Davis; Yong Ho Park
Journal:  Clin Vaccine Immunol       Date:  2006-08-30

2.  Changes in activation markers and cell membrane receptors on human peripheral blood T lymphocytes during cell cycle progression after PHA stimulation.

Authors:  T A Poulton; A Gallagher; R C Potts; J S Beck
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

3.  Flow cytometric analysis of the stimulatory response of T cell subsets from normal and HIV-1+ individuals to various mitogenic stimuli in vitro.

Authors:  E Medina; N Borthwick; M A Johnson; S Miller; M Bofill
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

4.  Increased state of activation of CD4 positive T cells and elevated interferon gamma production in pouchitis.

Authors:  A Stallmach; F Schäfer; S Hoffmann; S Weber; I Müller-Molaian; T Schneider; G Köhne; K W Ecker; G Feifel; M Zeitz
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

5.  Study of T-cell activation in type I diabetic patients and pre-type I diabetic subjects by cytometric analysis: antigen expression defect in vitro.

Authors:  C Giordano; R De Maria; M Todaro; G Stassi; A Mattina; P Richiusa; G Galluzzo; F Pantó; A Galluzzo
Journal:  J Clin Immunol       Date:  1993-01       Impact factor: 8.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.